Small but specialized Lehigh Valley Genomics is a high-complexity CLIA laboratory offering NGS and PCR diagnostic testing to physician partners nationwide. This indicates strong potential for expanding MSP/ referral partner programs and managed care collaboration to grow test volumes with diversified offerings.

National reach Although based in Bethlehem, LVG serves clinical practices across the United States, suggesting opportunity to scale partnerships with multi-state networks, ambulatory labs, and health systems seeking centralized high-complexity testing with physician-driven workflows.

Technology stack LVG’s digital footprint includes modern web technologies and e-commerce elements, implying readiness for direct-to-practice ordering, patient portal integrations, and streamlined test ordering that can be leveraged to reduce turnaround times and improve client experience.

Revenue opportunity With reported annual revenue in the range of 1M–10M and a lean employee base, LVG may benefit from scalable outsourcing, co-developed menus for high-margin validation panels, and pilot programs with reference laboratories to increase test mix and utilization.

Growth potential Founder-led clinical focus and cutting-edge diagnostics position LVG for expansion into next-gen sequencing panels, rare disease testing, and targeted oncology/genetic screening partnerships, offering multiple avenues for strategic alliances and sales targets.